Meeting ID: 945 3456 6430
Phone or Conference room password: 793622
One Click Join from a PC, Mac, Linux, iOS or Android device:
Keynote Speaker: Mina C. Hosseinipour, MD, MPH
Injectable PrEP, the game changer for HIV prevention?
Dr. Hosseinipour is the Scientific Director of the UNC Project in Lilongwe Malawi and Professor of Medicine at the University of North Carolina at Chapel Hill School of Medicine. Trained in internal medicine, infectious diseases and epidemiology, she has been engaged in HIV Treatment and Prevention clinical trials since 2001. Most recently, she has served as the co-Chair for the HPTN 084, a prevention study comparing injectable Cabotegravir to oral Truvada among cis-gender women. She also directs several research capacity building programs in Malawi, primarily focused on implementation science.
ESI Speaker: Matthew Spinelli, MD, MAS
SARS-CoV-2 Incidence, Clinical Outcomes, and Vaccination among People Living with HIV
Matt Spinelli is an HIV/ID physician with training in implementation science and clinical research methods who uses these approaches to support PrEP and HIV care implementation, ART adherence, and retention in care. A key tool we are using in this work is a point-of-care urine tenofovir test that can provide real-time adherence information to clinicians to drive adherence interventions. He is the co-director of the Implementation Science Short Course and the Individual-Level Intervention Design course in the UCSF Department of Epidemiology and a member of the Partnership for Research in Implementation Science for Equity, a collaboration between the SF Department of Public Health and UCSF that seeks to use implementation science methods to advance health equity. More recently, he leads projects on the intersection of the HIV and COVID-19 epidemics using epidemiological, translational, and socio-behavioral methods.